Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

Back to all news

DEA Virtual Diversion Pharmaceutical Awareness Training 2022

Posted 7/27/2022

Drug Enforcement Administration (DEA) will be hosting six, one-day training webinars for pharmacists and pharmacy technicians employed by pharmacies or hospitals/clinics that are registered with DEA.

PLEASE NOTE: The training will be held from 1:30 p.m. to 5:00 p.m. Eastern Standard Time (Please be cognizant and verify your individual time zone).

Each session will have a maximum capacity of 3,000 participants. It is highly recommended you register as early as possible and only register for one session as the same virtual session will be held on all six days.

Wednesday ? July 27, 2022

Registration for July Virtual Pharmaceutical Awareness Training

Registration for other sessions will open in early August.

Friday ? August 12, 2022
Thursday - August 18, 2022
Saturday ? August 20, 2022
Saturday ? September 10, 2022
Wednesday ? September 14, 2022

Upon completion of this activity, participants should be better able to:

  • Understand the state of the Opioid Crisis today and identify current drug trends
  • Learn where to locate DEA regulations and other resources
  • Recognize drug diversion and learn about healthcare fraud schemes
  • Understand prescribing and applying DEA record keeping regulations

There is no registration fee for these sessions. See Agenda for additional information.

This activity is approved for 3.50 contact hour(s) of continuing education (which includes 0.00 hour(s) of pharmacology) by the National Association of Boards of Pharmacy?. This activity was planned in accordance with NABP Accreditation Standards and Policies.

Back to all news

Sponsor Spotlight

COMPASS Pathways


COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more https://www.compasspathways.com

All Sponsors